Clinical trial
Beta Blockade in Critical Injury
NCT00356187 · Denver Health and Hospital Authority, Other · Terminated
Key facts
| NCT number | NCT00356187 |
|---|---|
| Title | Beta Blockade in Critical Injury |
| Official title | Beta-blockade Reduces Catabolism in Severely Injured Trauma Patients |
| Lead sponsor | Denver Health and Hospital Authority, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Trauma |
| Intervention type | Drug |
| Interventions | Propranolol |
| Enrollment | 15 |
| Start date | Feb 15, 2006 |
| Primary completion | Jan 31, 2009 |
| Completion | Jan 31, 2009 |
| First posted | Jul 25, 2006 |
| Last update posted | Mar 15, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: